My conclusion is that markets in organs are the best available way to enable persons with defective organs to get transplants much more quickly than under the present system. I do not find the arguments against allowing the sale of organs compelling, especially when weighed against the number of lives that would be saved by the increased supply stimulated by financial incentives.
